Anúncio
Anúncio

RMD

RMD logo

ResMed Inc.

250.92
USD
Patrocinado
+2.71
+1.09%
08 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

251.55

+0.64
+0.25%

Relatórios de Lucros RMD

Rácio de surpresa positiva

RMD separação 26 de 39 últimas estimativas.

67%

Próximo Relatório

Data do Próximo Relatório
22 de jan. de 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.41B
/
$2.74
Mudanças implicadas de Q1 26 (Revenue/ EPS)
+5.57%
/
+7.87%
Mudanças implicadas de Q2 25 (Revenue/ EPS)
+9.97%
/
+12.76%

ResMed Inc. earnings per share and revenue

On 30 de out. de 2025, RMD reported earnings of 2.54 USD per share (EPS) for Q1 26, missing the estimate of 2.57 USD, resulting in a -1.16% surprise. Revenue reached 1.34 bilhão, compared to an expected 1.34 bilhão, with a -0.64% difference. The market reacted with a -2.13% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 17 analistas forecast an EPS of 2.74 USD, with revenue projected to reach 1.41 bilhão USD, implying an aumentar of 7.87% EPS, and aumentar of 5.57% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
$0.05
Real
$0.10
Surpresa
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
-$0.20
Real
-$0.41
Surpresa
-100.98%
FAQ
For Q1 2026, ResMed Inc. reported EPS of $2.54, missing estimates by -1.16%, and revenue of $1.34B, -0.64% below expectations.
The stock price moved down -2.13%, changed from $252.26 before the earnings release to $246.88 the day after.
The next earning report is scheduled for 22 de jan. de 2026.
Based on 17 analistas, ResMed Inc. is expected to report EPS of $2.74 and revenue of $1.41B for Q2 2026.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio